Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1
Clinical trial NCT04246723 · COMPLETED
Trial details
- NCT number
- NCT04246723
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2020-04-08
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.